Home Cart Sign in  
Chemical Structure| 41432-97-7 Chemical Structure| 41432-97-7

Structure of Bleomycin A2
CAS No.: 41432-97-7

Chemical Structure| 41432-97-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Bleomycin A2 is an anti-tumor antibiotic that promotes DNA degradation and possesses AspH inhibitory activity with an IC50 of 1.47 μM. It induces DNA damage to exert anti-tumor effects and is widely used in cancer therapy and studies on DNA repair mechanisms.

Synonyms: Bleomycin A2 sulfate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Bleomycin A2

CAS No. :41432-97-7
Formula : C55H85N17O25S4
M.W : 1512.62
SMILES Code : C[S+](CCCNC(C1=CSC(C2=CSC(CCNC(C(C(O)C)NC(C(C)C(O)C(C)NC(C(C(O[C@H]3[C@@H](O[C@@H]4[C@@H](O)[C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O4)[C@@H](O)[C@H](O)[C@H](CO)O3)C5=CN=CN5)NC(C6=NC(C(NCC(N)C(N)=O)CC(N)=O)=NC(N)=C6C)=O)=O)=O)=O)=N2)=N1)=O)C.[O-]S(=O)(O)=O
Synonyms :
Bleomycin A2 sulfate
MDL No. :MFCD00070310
InChI Key :WUIABRMSWOKTOF-OYALTWQYSA-N
Pubchem ID :9812642

Safety of Bleomycin A2

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Bleomycin A2

DNA

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01435018 HIV-1 Infection Phase 3 Active, not recruiting March 13, 2020 Brazil ... More >> Instituto de Pesquisa Clinica Evandro Chagas (12101) Rio de Janeiro, Brazil, 21045 Kenya Moi University International Clnical Trials Unit Eldoret, Kenya, 30100 KMRI / Walter Reed Project Clinical Research Center Kericho, Kenya Kenya Medical Research Institute/Center for Disease Control (KEMRI/CDC) CRS (31460) Kisumu, Kenya, 40100 Malawi Univ. of Malawi, John Hopkins Project Blantyre, Malawi South Africa Family Clinical Research Unit (FAM-CUR) CRS (8950) Cape Town, West Cape, South Africa, 7505 Durban Adult HIV CRS (11201) Durban, South Africa, 4013 SF University of Witwatersrand Johannesburg, South Africa Uganda Uganda Cancer Institute ACTG CRS Kampala, Uganda Zimbabwe UZ-Parirenyatwa CRS (30313) Harare, Zimbabwe Less <<
NCT03159897 Hodgkin Lymphoma Phase 3 Recruiting January 2023 -
NCT02292979 Hodgkin Lymphoma Phase 2 Active, not recruiting August 2022 -
NCT00000658 Lymphoma, Non-Hodgkin ... More >> HIV Infections Less << Phase 3 Completed - United States, California ... More >> USC CRS Los Angeles, California, United States, 900331079 UCLA CARE Center CRS Los Angeles, California, United States, 90095 Ucsf Aids Crs San Francisco, California, United States, 941102859 United States, Colorado University of Colorado Hospital CRS Aurora, Colorado, United States, 80262 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States, 60612 United States, Indiana Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States, 462025250 United States, Maryland Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States United States, Massachusetts Beth Israel Deaconess Med. Ctr., ACTG CRS Boston, Massachusetts, United States, 02118 Beth Israel Deaconess - East Campus A0102 CRS Boston, Massachusetts, United States, 02215 Bmc Actg Crs Boston, Massachusetts, United States United States, Missouri Washington U CRS St. Louis, Missouri, United States United States, New York SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States, 14215 Beth Israel Med. Ctr. (Mt. Sinai) New York, New York, United States, 02215 NY Univ. HIV/AIDS CRS New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Ctr. New York, New York, United States, 10021 Univ. of Rochester ACTG CRS Rochester, New York, United States, 14642 United States, North Carolina Unc Aids Crs Chapel Hill, North Carolina, United States, 275997215 United States, Ohio Case CRS Cleveland, Ohio, United States The Ohio State Univ. AIDS CRS Columbus, Ohio, United States, 432101228 United States, Pennsylvania Hosp. of the Univ. of Pennsylvania CRS Philadelphia, Pennsylvania, United States, 19104 Pitt CRS Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01578967 Hodgkin Lymphoma, Adult Not Applicable Active, not recruiting August 10, 2021 United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Levine Cancer Istitute, Carolinas Health Care system Charlotte, North Carolina, United States, 28204 Rex Cancer Center Raleigh, North Carolina, United States, 27607 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37240 Less <<
NCT01578967 - Active, not recruiting - -
NCT00000689 Lymphoma, Non-Hodgkin ... More >> HIV Infections Less << Phase 1 Completed - United States, California ... More >> USC CRS Los Angeles, California, United States, 90033 Less <<
NCT02782754 Intracranial Germinoma Phase 2 Unknown - Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung    82-2-3410-3529    kwsped@skku.edu    Principal Investigator: Ki Woong Sung Less <<
NCT01026220 Childhood Nodular Lymphocyte P... More >>redominant Hodgkin Lymphoma Stage III Childhood Hodgkin Lymphoma Stage IV Childhood Hodgkin Lymphoma Less << Phase 3 Completed - -
NCT00352027 - Active, not recruiting - -
NCT00104676 Extragonadal Germ Cell Tumor ... More >> Teratoma Testicular Germ Cell Tumor Less << Phase 3 Unknown - United States, Texas ... More >> M. D. Anderson Cancer Center at University of Texas Recruiting Houston, Texas, United States, 77030-4009 Contact: Clinical Trials Office - M. D. Anderson Cancer Center at the U    713-792-3245       France Centre Paul Papin Recruiting Angers, France, 49100 Contact: Remy Delva    33-49-800-918-507       Institut Bergonie Recruiting Bordeaux, France, 33076 Contact: Nguyen Binh Bui, MD    33-5-5633-3813       C.H.U. de Brest Recruiting Brest, France, 29609 Contact: Jean-Pierre Malhaire, MD    33-298-223-333 ext. 233-95       Centre Regional Francois Baclesse Recruiting Caen, France, 14076 Contact: Emmanuel Sevin, MD    33-2-3145-5000    e.sevin@baclesse.fr    CHU de Grenoble - Hopital de la Tronche Recruiting Grenoble, France, 38043 Contact: Francois Ringeisen    33-4-7676-5537       Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Armelle Caty, MD    33-32-029-5959    acaty@o-lambret.fr    Centre Leon Berard Recruiting Lyon, France, 69008 Contact: Aude Flechon    33-4-78-78-26-45       Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Recruiting Marseille, France, 13273 Contact: Gwenaelle Gravis, MD    33-4-9122-3740    gravisg@marseille.fnclcc.fr    Hopital Notre-Dame de Bon Secours Recruiting Metz, France, 57038 Contact: Christian Platini, MD    33-3-8755-3554    cplatini@chr-metz-thionville.fr    Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: Stephane Culine, MD    33-4-6761-3755    stculine@valdorel.fnclcc.fr    CRLCC Nantes - Atlantique Recruiting Nantes-Saint Herblain, France, 44805 Contact: Frederic Rolland, MD    33-2-40-67-99-76    F-rolland@nantes.fnclcc.fr    Centre Antoine Lacassagne Recruiting Nice, France, 06189 Contact: Antoine Thyss, MD    33-04-9203-1538    antoine.thyss@cal.nice.fnclcc.fr    Hopital Europeen Georges Pompidou Recruiting Paris, France, 75015 Contact: Stephane Oudard, MD, PhD    33-1-56-093-476    stephane.oudard@hop.egp.ap-hop-paris.fr    Hopital Tenon Recruiting Paris, France, 75970 Contact: Jean-Pierre Lotz, MD    33-1-5601-6058    jean-pierre.lotz@tnn.ap-hop-paris.fr    Institut Jean Godinot Recruiting Reims, France, 51056 Contact: Jean-Christophe Eymard, MD    33-03-2650-4444    jc.eymard@reims.fnclcc.fr    Centre Eugene Marquis Recruiting Rennes, France, 35042 Contact: Pierre Kerbrat, MD, PhD    33-299-253-280    kerbrat@rennes.fnclcc.fr    Centre Hospitalier de Rodez Recruiting Rodez, France, 12027 Contact: Laurent Mosser    33-05-6575-1212       Centre Henri Becquerel Recruiting Rouen, France, 76038 Contact: Paule Chinet-Charrot    33-2-3208-2222       Institut Claudius Regaud Recruiting Toulouse, France, 31052 Contact: Christine Chevreau-Dalbianco, MD    33-56-142-4114    chevreau.christine@claudiusregaud.fr    Centre Hospitalier Universitaire Bretonneau de Tours Recruiting Tours, France, 37044 Contact: Claude Linassier, MD, PhD    33-2-4747-3827    linassier@med.univ-tours.fr    Centre Alexis Vautrin Recruiting Vandoeuvre-les-Nancy, France, 54511 Contact: Lionnel Geoffrois, MD    33-3-8359-8400       Institut Gustave Roussy Recruiting Villejuif, France, F-94805 Contact: Karim Fizazi, MD, PhD    33-1-4211-4559    fizazi@igr.fr    Slovakia National Cancer Institute - Bratislava Recruiting Bratislava, Slovakia, 833 10 Contact: Maria Reckova, MD    421-2-5937-8366    maria.reckova@nou.sk Less <<
NCT00352027 Hodgkin's Lymphoma Phase 2 Active, not recruiting November 2022 United States, California ... More >> Stanford University Medical Center Palo Alto, California, United States, 94304 Rady Children's Hospital San Diego San Diego, California, United States, 92123 United States, Maine Maine Children's Medical Center Portland, Maine, United States, 04102-3175 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00736320 Hodgkin Lymphoma Phase 3 Active, not recruiting May 2020 Germany ... More >> 1st Dept. of Medicine, Cologne University Hospital Cologne, Germany Less <<
NCT00005867 Lymphoma Phase 3 Completed - United Kingdom ... More >> Stoke Mandeville Hospital Aylesbury-Buckinghamshire, England, United Kingdom, HP21 8AL Horton Hospital Banbury, England, United Kingdom, OX16 9AL Basildon University Hospital Basildon, England, United Kingdom, SS16 5NL Birmingham Heartlands Hospital Birmingham, England, United Kingdom, B9 5SS Bradford Hospitals NHS Trust Bradford, England, United Kingdom, BD9 6RJ Bristol Haematology and Oncology Centre Bristol, England, United Kingdom, BS2 8ED Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Cheltenham General Hospital Cheltenham, England, United Kingdom, GL53 7AN Countess of Chester Hospital NHS Foundation Trust Chester, England, United Kingdom, CH2 1UL Saint Richards Hospital Chichester, England, United Kingdom, P019 4SE Essex County Hospital Colchester, England, United Kingdom, C03 3NB Walsgrave Hospital Coventry, England, United Kingdom, CV2 2DX Russells Hall Hospital Dudley, England, United Kingdom, DY1 2HQ Chase Farm Hospital Enfield, England, United Kingdom, EN 28 JL Medway Maritime Hospital Gillingham Kent, England, United Kingdom, ME7 5NY Hull Royal Infirmary Hull, England, United Kingdom, HU3 2KZ Hinchingbrooke Hospital Huntingdon, England, United Kingdom, PE18 6NT Queen Elizabeth Hospital King's Lynn, England, United Kingdom, PE30 4ET Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool and Broadgreen Hospitals NHS Trust Liverpool, England, United Kingdom, L7 8XP Aintree University Hospital Liverpool, England, United Kingdom, L9 7AL Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE St. Thomas' Hospital London, England, United Kingdom, SE1 7EH St. George's Hospital London, England, United Kingdom, SW17 0QT Middlesex Hospital London, England, United Kingdom, WC1E 6HX Clatterbridge Centre for Oncology NHS Trust Merseyside, England, United Kingdom, CH63 4JY Norfolk and Norwich University Hospital Norwich, England, United Kingdom, NR4 7UY Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Pontefract General Infirmary Pontefract West Yorkshire, England, United Kingdom, WF8 1PL Oldchurch Hospital Romford, England, United Kingdom, RM7 OBE Scunthorpe General Hospital Scunthorpe, England, United Kingdom, DN15 7BH Cancer Research Centre at Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Southampton University Hospital NHS Trust Southampton, England, United Kingdom, SO16 6YD University Hospital of North Staffordshire Stoke-On-Trent Staffs, England, United Kingdom, ST4 6QG East Surrey Hospital Surrey, England, United Kingdom, RH1 5RH Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Sandwell General Hospital West Bromwich, England, United Kingdom, B71 4HJ Cancer Care Centre at York Hospital York, England, United Kingdom, Y031 8HE Centre for Cancer Research and Cell Biology at Belfast City Hospital Belfast, Northern Ireland, United Kingdom, BT9 7AB Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Pinderfields Hospital NHS Trust Wakefield, Scotland, United Kingdom, WF1 4DG Ysbyty Gwynedd Bangor, Wales, United Kingdom, LL57 2PW University Hospital of Wales Cardiff, Wales, United Kingdom, CF14 4XN Glan Clywd District General Hospital Rhyl, Denbighshire, Wales, United Kingdom, LL 18 5UJ Mount Vernon Cancer Centre at Mount Vernon Hospital Rhyl, Denbighshire, Wales, United Kingdom, LL 18 5UJ Less <<
NCT00038558 Hodgkin Disease Phase 3 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00225173 Hodgkin Disease Phase 2 Terminated - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305 Less <<
NCT01026220 - Completed - -
NCT00429754 Nausea Vomiti... More >>ng Less << Phase 4 Withdrawn(change of study popu... More >>lation and chemotherapeutic regimen) Less << - -
NCT02758717 Ann Arbor Stage IB Hodgkin Lym... More >>phoma Ann Arbor Stage II Hodgkin Lymphoma Ann Arbor Stage IIA Hodgkin Lymphoma Ann Arbor Stage IIB Hodgkin Lymphoma Ann Arbor Stage III Hodgkin Lymphoma Ann Arbor Stage IIIA Hodgkin Lymphoma Ann Arbor Stage IIIB Hodgkin Lymphoma Ann Arbor Stage IV Hodgkin Lymphoma Ann Arbor Stage IVA Hodgkin Lymphoma Ann Arbor Stage IVB Hodgkin Lymphoma Classic Hodgkin Lymphoma Less << Phase 2 Recruiting May 13, 2024 United States, California ... More >> Stanford Cancer Institute Palo Alto Recruiting Palo Alto, California, United States, 94304 Contact: Ann Moffat    650-721-4096    amoffat@stanford.edu    Principal Investigator: Ranjana H. Advani          United States, District of Columbia MedStar Georgetown University Hospital Recruiting Washington, District of Columbia, United States, 20007 Contact: Pari Ramzi    202-784-0038    ramzip1@georgetown.edu    Principal Investigator: Bruce D. Cheson          United States, Illinois University of Chicago Comprehensive Cancer Center Withdrawn Chicago, Illinois, United States, 60637 United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Mayo Clinic Clinical Trials Office    507-538-7623    clinicaltrials@mayo.edu    Principal Investigator: Stephen M. Ansell          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Kelly Hoye    314-362-4206    khoye@wustl.edu    Principal Investigator: Nancy L. Bartlett          United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Kara M. Yannotti    551-996-5900    Kara.Yannotti@HackensackMeridian.org    Principal Investigator: Tatyana A. Feldman          United States, New York Laura and Isaac Perlmutter Cancer Center at NYU Langone Recruiting New York, New York, United States, 10016 Contact: Mohammad Maher Abdul-Hay    212-731-5670    Maher.Abdulhay@nyumc.org    Principal Investigator: Catherine S. Diefenbach          United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Rashmeet Reen    614-688-9283    rashmeet.reen@osumc.edu    Principal Investigator: Kristie A. Blum          United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Emily Wesson    713-794-5656    etwesson@mdanderson.org    Principal Investigator: Michelle A. Fanale Less <<
NCT00848289 - Recruiting August 2019 United States, Texas ... More >> Baylor College of Medicine Terminated Houston, Texas, United States, 77030 MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Xifeng Wu, MD    713-792-3020    xwu@mdanderson.org Less <<
NCT00000626 HIV Infections ... More >> Hodgkin's Disease Less << Phase 2 Completed - United States, Alabama ... More >> Alabama Therapeutics CRS Birmingham, Alabama, United States, 35294 United States, California USC CRS Los Angeles, California, United States, 900331079 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 United States, Indiana Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States, 462025250 United States, Missouri St. Louis ConnectCare, Infectious Diseases Clinic St Louis, Missouri, United States, 63112 Washington U CRS St. Louis, Missouri, United States United States, New York SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States United States, Ohio The Ohio State Univ. AIDS CRS Columbus, Ohio, United States, 432101228 Less <<
NCT01468740 HIV-associated Hodgkin Lymphom... More >>a Less << Phase 2 Unknown July 2012 Germany ... More >> Vivantes Auguste Victoria Klinikum Recruiting Berlin, Germany, 12157 Contact: Markus Müller, MD    0049 30 130 20 2321    Markus.Mueller2@vivantes.de    Contact: Marcel Berger, MD    0049 30 130 20 2321    Marcel.Berger@vivantes.de    Sub-Investigator: Markus Müller, MD          Sub-Investigator: Marcel Berger, MD          Principal Investigator: Keikawus Arasteh, MD          Ärzteforum Seestrasse Recruiting Berlin, Germany, 13347 Contact: Jan Siehl, MD    0049 30 455095-0    jan.siehl@aerzteforum-seestrasse.de    Principal Investigator: Jan Siehl, MD          Universiy of Bonn Recruiting Bonn, Germany, 53127 Contact: Juergen Rockstroh, MD    0049 228 287 16558    Rockstroh@uni-bonn.de;    Principal Investigator: Jürgen Rockstroh, MD          University of Cologne Recruiting Cologne, Germany, 50924 Contact: Christoph Wyen, MD    0049 221 478 88835    christoph.wyen@uk-koeln.de    Contact: Gerd Fätkenheuer, MD    0049 221 478 4886    g.faetkenheuer@uni-koeln.de    Sub-Investigator: Christoph Wyen, MD          Principal Investigator: Gerd Fätkenheuer, MD          University of Frankfurt Recruiting Frankfurt, Germany, 60590 Contact: Timo Wolf, MD    0049 69 6301 5452    Timo.Wolf@kgu.de    Principal Investigator: Timo Wolf, MD          Asklepios Klinikum St. Georg Recruiting Hamburg, Germany, 20099 Contact: Maike Nickelsen, MD    0049 40 18 18 85 20 05    m.nickelsen@asklepios.com    Principal Investigator: Maike Nickelsen, MD          Infektionsmedizinisches Zentrum Hamburg Recruiting Hamburg, Germany, 20146 Contact: Christian Hoffmann, MD    0049 40 4132420    hoffmann@ich-hamburg.de;    Principal Investigator: Christian Hoffmann, MD          Harlaching Hospital Recruiting Munich, Germany, 81545 Contact: Marcus Hentrich, MD    0049 89 6210 2663 or 2731    marcus.hentrich@klinikum-muenchen.de    Principal Investigator: Marcus Hentrich, MD Less <<
NCT00301782 Extragonadal Germ Cell Tumor ... More >> Teratoma Testicular Germ Cell Tumor Less << Phase 2 Completed - United Kingdom ... More >> Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Birmingham, England, United Kingdom, B15 2TH Bristol Haematology and Oncology Centre Bristol, England, United Kingdom, BS2 8ED Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Gloucestershire Oncology Centre at Cheltenham General Hospital Cheltenham, England, United Kingdom, GL53 7AN Walsgrave Hospital Coventry, England, United Kingdom, CV2 2DX Royal Devon and Exeter Hospital Exeter, England, United Kingdom, EX2 5DW Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE University College of London Hospitals London, England, United Kingdom, WIT 3AA Christie Hospital Manchester, England, United Kingdom, M20 4BX Clatterbridge Centre for Oncology Merseyside, England, United Kingdom, CH63 4JY Nottingham City Hospital Nottingham, England, United Kingdom, NG5 1PB Rosemere Cancer Centre at Royal Preston Hospital Preston, England, United Kingdom, PR2 9HT Berkshire Cancer Centre at Royal Berkshire Hospital Reading, England, United Kingdom, RG1 5AN Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom, G11 6NT Raigmore Hospital Inverness, Scotland, United Kingdom, 1V2 3UJ Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Less <<
NCT01251107 Hodgkin Lymphoma Phase 3 Completed - Italy ... More >> Fondazione IRCCS Istituto Nazionale di Tumori di Milano Milano, Italy Less <<
NCT00901303 Hodgkin's Lymphoma Not Applicable Terminated(The study was termi... More >>nated due to lack of accrual.) Less << - United States, New York ... More >> Weill Cornell Medical College New York, New York, United States, 10021 Less <<
NCT00005578 Cardiac Toxicity ... More >> Lymphoma Less << Phase 3 Completed - -
NCT01118026 Lymphoma Phase 2 Active, not recruiting - -
NCT01390584 Lymphoma Phase 2 Terminated(slow accrual) - United States, California ... More >> Stanford Cancer Center Stanford, California, United States, 94305-5824 United States, Pennsylvania McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center Reading, Pennsylvania, United States, 19612-6052 Less <<
NCT00901303 - Terminated(The study was termi... More >>nated due to lack of accrual.) Less << - -
NCT00369681 Lymphoma Phase 2 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 United States, Iowa Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242-1009 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT00369681 - Completed - -
NCT00002827 Cardiac Toxicity ... More >> Lymphoma Less << Phase 3 Completed - -
NCT00135499 Lymphoma, Large-Cell, Diffuse Phase 3 Terminated(Recruitment too low... More >>) Less << - Belgium ... More >> Groupe d'Etude des Lymphomes de l'adulte Yvoir, Belgium France Hôpital Henri Mondor Créteil, France, 94010 Hôpital Saint Louis Paris, France, 75010 Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Institut Gustave Roussy Villejuif, France Switzerland Schweirische Arbeitsgruppe fur klinische Krebsforschung Lausanne, Switzerland Less <<
NCT03142061 Advanced Inoperable Vulva Carc... More >>inoma Less << Not Applicable Recruiting December 31, 2019 Germany ... More >> Department of Women's Health Recruiting Tübingen, Germany, 72076 Contact: Harald Seeger, Prof. Dr. Less <<
NCT00822120 Lymphoma Nonn... More >>eoplastic Condition Less << Phase 2 Active, not recruiting April 2020 -
NCT00053352 Childhood Embryonal Tumor ... More >> Childhood Extracranial Germ Cell Tumor Childhood Extragonadal Germ Cell Tumor Childhood Malignant Ovarian Germ Cell Tumor Childhood Malignant Testicular Germ Cell Tumor Childhood Teratoma Ovarian Embryonal Carcinoma Ovarian Yolk Sac Tumor Stage II Malignant Testicular Germ Cell Tumor Stage IIA Ovarian Germ Cell Tumor Stage IIB Ovarian Germ Cell Tumor Stage IIC Ovarian Germ Cell Tumor Stage III Malignant Testicular Germ Cell Tumor Stage IIIA Ovarian Germ Cell Tumor Stage IIIB Ovarian Germ Cell Tumor Stage IIIC Ovarian Germ Cell Tumor Testicular Choriocarcinoma and Yolk Sac Tumor Testicular Embryonal Carcinoma Less << Phase 3 Completed - -
NCT03755804 Hodgkin Lymphoma Phase 2 Recruiting July 1, 2028 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Jamie Flerlage, MD, MS    866-278-5833    referralinfo@stjude.org Less <<
NCT00822120 - Active, not recruiting - -
NCT02298283 Hodgkin Lymphoma Phase 2 Recruiting February 2021 France ... More >> CH Victor Dupouy Recruiting Argenteuil, France, 95100 Contact: Driss CHAOUI, MD       driss.chaoui@ch-argenteuil.fr    Principal Investigator: Driss CHAOUI, MD          Polyclinique Bordeaux Nord Recruiting Bordeaux, France, 33300 Contact: Olivier FITOUSSI, MD       o.fitoussi@bordeauxnord.com    Contact: Olivier          Principal Investigator: FITOUSSI, MD          Centre François Baclesse Recruiting Caen, France, 14076 Contact: Christophe FRUCHART, MD       c.fruchart@baclesse.unicancer.fr    Principal Investigator: Christophe FRUCHART, MD          CH de Chambéry Recruiting Chambéry, France, 73011 Contact: Gian Mathéo PICA, MD       gian-matteo.pica@ch-chambery.fr    Principal Investigator: Gian Mathéo PICA, MD          CH Sud Francilien Recruiting Corbeil-Essonnes, France, 91108 Contact: Bertrand JOLY, MD       bertrand.joly@ch-sud-francilien.fr    Principal Investigator: Bertrand JOLY, MD          Hôpital Henri Mondor Recruiting Creteil, France, 94010 Contact: Corinne HAIOUN, Prof       corinne.haioun@hmn.aphp.fr    Principal Investigator: Corinne HAIOUN, Prof          CHU de Dijon - Hôpital le Bocage Recruiting Dijon, France, 21034 Contact: Olivier CASASNOVAS, MD       olivier.casasnovas@chu-dijon.fr    Principal Investigator: Olivier CASASNOVAS, MD          Hôpital André Mignot Recruiting Le Chesnay, France, 78157 Contact: Hassan FARHAT, MD       hfarhat@ch-versailles.fr    Principal Investigator: Hassan FARHAT, MD          Clinique Victor Hugo Recruiting Le Mans, France, 72000 Contact: Katell LE DÛ, MD       k.ledu@cjb72.org    Principal Investigator: Katell LE DÛ, MD          CHRU Lille - Hôpital Claude Huriez Recruiting Lille, France, 59037 Contact: Franck MORSCHHAUSER, Prof       franck.morschhauser@chru-lille.fr    Principal Investigator: Franck MORSCHHAUSER, Prof          CHU de Limoges Recruiting Limoges, France, 87042 Contact: Mohamed TOUATI, MD       mohamed.touati@chu-limoges.fr    Principal Investigator: Mohamed TOUATI, MD          Centre Léon Bérard Recruiting Lyon, France, 69008 Contact: Emmanuelle NICOLAS- VIRELIZIER, MD       emmanuelle.nicolas@lyon.unicancer.fr    Principal Investigator: Emmanuelle NICOLAS- VIRELIZIER, MD          Institut Paoli Calmette Recruiting Marseille, France, 13273 Contact: Réda BOUABDALLAH, MD       bouabdallahr@ipc.unicancer.fr    Principal Investigator: Réda BOUABDALLAH, MD          Hôpital de la Conception Recruiting Marseille, France, 13385 Contact: Régis COSTELLO, Prof       regis.costello@free.fr    Principal Investigator: Régis COSTELLO, Prof          CHU Montpellier - Saint ELOI Recruiting Montpellier, France, 34295 Contact: Philippe QUITTET, MD       p-quittet@chu-montpellier.fr    Principal Investigator: Philippe QUITTET, MD          CHU de Nantes Recruiting Nantes, France, 44093 Contact: Thomas GASTINNE, MD       thomas.gastinne@chu-nantes.fr    Principal Investigator: Thomas GASTINNE, MD          Hôpital Saint Louis Recruiting Paris cedex 10, France, 75475 Contact: Pauline BRICE, MD       pauline.brice@sls.aphp.fr    Principal Investigator: Pauline BRICE, MD          Hôpital Cochin Recruiting Paris, France, 75004 Contact: Bénédicte DEAU-FISCHER, MD       benedicte.deau-fischer@cch.aphp.fr    Principal Investigator: Bénédicte DEAU-FISCHER, MD          Hôpital de la Pitié Salpétrière Recruiting Paris, France, 75651 Contact: Jean GABARRE, MD       jean.gabarre@psl.aphp.fr    Principal Investigator: Jean GABARRE, MD          CH Perpignan Recruiting Perpignan, France, 66046 Contact: Laurence SANHES, MD       laurence.sanhes@ch-perpignan.fr    Principal Investigator: Laurence SANHES, MD          Hôpital Haut Lévêque Recruiting Pessac, France, 33604 Contact: Krimo BOUABDALLAH, MD       krimo.bouabdallah@chu-bordeaux.fr    Principal Investigator: Krimo BOUABDALLAH, MD          CHU Lyon Sud Recruiting Pierre Bénite Cedex, France, 69495 Contact: Gilles SALLES, Prof       gilles.salles@chu-lyon.fr    Principal Investigator: Gilles SALLES, Prof          CHU Robert Debre Recruiting Reims, France, 51092 Contact: Alain DELMER, MD       adelmer@chu-reims.fr    Principal Investigator: Alain DELMER, MD          CHU Pontchaillou Recruiting Rennes, France, 35033 Contact: Thierry LAMY de la CHAPELLE, Prof       thierry.lamy.de.la.chapelle@chu-rennes.fr    Principal Investigator: Thierry LAMY de la CHAPELLE, Prof          Centre Henri Becquerel Recruiting Rouen, France, 76000 Contact: Aspasia STAMATOULLAS, MD       aspasia.stamatoullas@chb.unicancer.fr    Principal Investigator: Aspasia STAMATOULLAS, MD          CHU de Strasbourg Recruiting Strasbourg, France, 67098 Contact: Luc-Matthieu FORNECKER, MD       luc-matthieu.fornecker@chru-strasbourg.fr    Principal Investigator: Luc-Matthieu FORNECKER, MD          I.U.C.T Oncopole Recruiting Toulouse, France, 31059 Contact: Cécile BOREL, MD       borel.c@chu-toulouse.fr    Principal Investigator: Cécile BOREL, MD          CHU Bretonneau Recruiting Tours, France, 37044 Contact: Marjan ERTAULT, MD       m.ertault@chu-tours.fr    Principal Investigator: Marjan ERTAULT, MD          CHU de Brabois Recruiting Vandœuvre-lès-Nancy, France, 54511 Contact: Serge BOLOGNA, MD       s.bologna@chu-nancy.fr    Principal Investigator: Serge BOLOGNA, MD          Gustave Roussy Cancer Campus Recruiting Villejuif, France, 94805 Contact: Vincent RIBRAG, MD       vincent.ribrag@gustaveroussy.fr    Principal Investigator: Vincent RIBRAG, MD Less <<
NCT00846742 Hodgkin Lymphoma Phase 2 Recruiting December 2021 United States, California ... More >> Packard Children's Hospital, Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Michael Link, MD    650-495-8815    mlink@stanford.edu    Principal Investigator: Michael Link, MD          Rady Children's Hospital- San Diego Recruiting San Diego, California, United States, 92123 Contact: Dennis Kuo, MD    858-966-5811    dkuo@rchsd.org    Principal Investigator: Dennis Kuo, MD          United States, Maine Maine Children's Cancer Program (MCCP) Recruiting Scarborough, Maine, United States, 04074 Contact: Eric Larsen, MD    207-396-7565    larsee1@mmc.org    Principal Investigator: Eric Larsen, MD          United States, Massachusetts Massachusetts General Hospital Cancer Center Withdrawn Boston, Massachusetts, United States, 02114 Dana-Farber Harvard Cancer Center Recruiting Boston, Massachusetts, United States, 02115 Contact: Amy Billett, MD    617-632-5640    amy_billett@dfci.harvard.edu    Principal Investigator: Amy Billett, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Monika Metzger, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Monika Metzger, MD          Canada, Ontario The Hospital for Sick Children Withdrawn Toronto, Ontario, Canada, M5G1X8 Less <<
NCT00136565 Peripheral T-cell Lymphoma Phase 2 Completed - Belgium ... More >> Groupe d'Etude des Lymphomes de l'Adulte Yvoir, Belgium France Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Institut Gustave Roussy Villejuif, France Less <<
NCT00654732 Classic Hodgkin Lymphoma ... More >> Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8 Less << Phase 2 Completed - United States, Florida ... More >> University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States, 33136 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01726374 Stage I Testicular Non-Seminom... More >>atous Germ Cell Tumor Less << Phase 3 Active, not recruiting August 2019 United Kingdom ... More >> Guy's Hospital London, England, United Kingdom, SE1 9RT Northampton General Hospital NHS Trust Northampton, England, United Kingdom, NN6 8BJ Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Aberdeen Royal Infirmary Aberdeen, United Kingdom Ysbyty Gwynedd Bangor, United Kingdom Queen Elizabeth Hospital Birmingham, United Kingdom Royal Sussex County Hospital Brighton, United Kingdom Bristol Haematology and Oncology Centre Bristol, United Kingdom Queen's Hospital Burton-on-Trent, United Kingdom Addenbrooke's Hospital Cambridge, United Kingdom Cheltenham General Hospital Cheltenham, United Kingdom Gloucestershire Royal Hospital Cheltenham, United Kingdom University Hospitals Coventry and Warwickshire NHS Trust Coventry, United Kingdom Royal Derby Hospital Derby, United Kingdom Western General Hospital Edinburgh, United Kingdom Royal Devon and Exeter Hospital Exeter, United Kingdom Beatson West of Scotland Cancer Centre Glasgow, United Kingdom Royal Surrey County Hospital Guildford, United Kingdom Castle Hill Hospital Hull, United Kingdom Ipswich Hospital Ipswich, United Kingdom St James's University Hospital Leeds, United Kingdom Leicester Royal Infirmary Leicester, United Kingdom Lincoln County Hospital Lincoln, United Kingdom Clatterbridge Centre for Oncology Liverpool, United Kingdom Royal Liverpool University Hospital Liverpool, United Kingdom St Bartholomew's Hospital London, United Kingdom University College Hospital London, United Kingdom Maidstone Hospital Maidstone, United Kingdom James Cook University Hospital Middlesbrough, United Kingdom Norfolk and Norwich University Hospital Norwich, United Kingdom Nottingham City Hospital Nottingham, United Kingdom Churchill Hospital Oxford, United Kingdom Weston Park Hospital Sheffield, United Kingdom Southampton General Hospital Southampton, United Kingdom Royal Marsden Hospital Sutton, United Kingdom Less <<
NCT00453232 Extragonadal Germ Cell Tumor ... More >> Teratoma Testicular Germ Cell Tumor Less << Phase 2 Completed - United Kingdom ... More >> Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle-Upon-Tyne, England, United Kingdom, NE4 6BE Churchill Hospital Oxford, England, United Kingdom, OX3 7LJ Edinburgh Cancer Centre at Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT00053352 - Completed - -
NCT02582697 Germ Cell Tumor Phase 3 Recruiting July 2023 Australia, New South Wales ... More >> Calvary Mater Newcastle Recruiting Newcastle, New South Wales, Australia, 2298 Contact: Louise Plowman       Louise.Plowman@calvarymater.org.au    Contact: Girish Mallesara       girish.mallesara@calvarymater.org.au    Principal Investigator: Girish Mallesara          Royal North Shore Hospital Recruiting St Leonards, New South Wales, Australia, 2065 Contact: Susan Kirby-Lewis       Susan.KirbyLewis@health.nsw.gov.au    Contact: Alexander Guminski       aguminski@nsccahs.health.nsw.gov.au    Principal Investigator: Alexander Guminski          Prince of Wales Hospital Recruiting Sydney, New South Wales, Australia, 2031 Contact: Daisy Buchanan       Daisy.buchanan@sesiahs.health.nsw.gov.au    Contact: Julie Howard       Julie.howard@sesiahs.health.nsw.gov.au    Principal Investigator: Elizabeth Hovey          Chris O'Brien Lifehouse Recruiting Sydney, New South Wales, Australia, 2050 Contact: Melissa Quaggiott       melissa.mcmahon@lh.org.au    Contact: Peter Grimison       peter.grimison@lh.org.au    Principal Investigator: Peter Grimison          Macquarie Cancer Clinical Trials Recruiting Sydney, New South Wales, Australia, 2109 Contact: Louise Francisco       louise.francisco@mq.edu.au    Contact: Radhika Butala       radhika.butala@mq.edu.au    Principal Investigator: Howard Gurney          Concord Repatriation General Hospital Recruiting Sydney, New South Wales, Australia, 2139 Contact: Kathy Hall       Kathy.Hall@sswahs.nsw.gov.au    Contact: Martin Stockler       martin.stockler@sydney.edu.au    Principal Investigator: Martin Stockler          Westmead Hospital Recruiting Sydney, New South Wales, Australia, 2145 Contact: Vicky Wegener       vicky.wegener@sydney.edu.au    Contact: Howard Gurney       howard_gurney@wmi.usyd.edu.au    Principal Investigator: Howard Gurney          Nepean Hospital Recruiting Sydney, New South Wales, Australia, 2751 Contact: Jeremy Jones       jeremy.jones@swahs.health.nsw.gov.au    Contact: Amanda Stevanovic       amanda.stevanovic@swahs.health.nsw.gov.au    Principal Investigator: Amanda Stevanovic          Tweed Hospital Recruiting Tweed Heads, New South Wales, Australia, 2485 Contact: Charmayne Chorlton       Charmayne.Chorlton@ncahs.health.nsw.gov.au    Contact: Ehtesham Abdi       eaabdi@mac.com    Principal Investigator: Ehtesham Abdi          SAN Clinical Trials Unit Recruiting Wahroonga, New South Wales, Australia, 2076 Contact: James McQuilan       James.McQuillan@sah.org.au    Contact: Gavin Marx       gmarx@nhog.com.au    Principal Investigator: Gavin Marx          Australia, Queensland Royal Brisbane & Women's Hospital Recruiting Brisbane, Queensland, Australia, 4029 Contact: Natasha Roberts       natasha.roberts@health.qld.gov.au    Contact: David Wyld       david.wyld@health.qld.gov.au    Principal Investigator: David Wyld          Princess Alexandra Recruiting Woolloongabba, Queensland, Australia, 4102 Contact: Paul Baxter       Paul.Baxter@health.qld.gov.au    Contact: Euan Walpole       Euan.Walpole@health.qld.gov.au    Principal Investigator: Euan Walpole          Australia, South Australia Royal Adelaide Hospital Recruiting Adelaide, South Australia, Australia, 5000 Contact: Hazel Bourke       hazel.bourke@health.sa.gov.au    Contact: Thean Hsiang Tan       hsiang.tan@health.sa.gov.au    Principal Investigator: Thean Tan          Flinders Medical Centre Recruiting Bedford Park, South Australia, Australia, 5042 Contact: Alex Scott-Hoy       Alex.Scott-Hoy@health.sa.gov.au    Contact: Ganessan Kichenadasse       Ganessan.Kichenadasse@health.sa.gov.au    Principal Investigator: Ganessan Kichenadasse          Australia, Tasmania Royal Hobart Hospital Recruiting Hobart, Tasmania, Australia, 7000 Contact: Lesley Oliver       lesley.oliver@dhhs.tas.gov.au    Contact: David Boadle       david.boadle@dhhs.tas.gov.au    Principal Investigator: David Boadle          Australia, Victoria Box Hill Hospital Recruiting Box Hill, Victoria, Australia, 3128 Contact: Lauren Mitchell       lauren.mitchell@monash.edu    Contact: Philip Parente       Phillip.parente@monash.edu    Principal Investigator: Philip Parente          Peter MacCallum Cancer Centre Recruiting East Melbourne, Victoria, Australia, 3002 Contact: Jennifer Petersen       jennifer.petersen@petermac.org    Contact: Guy Toner       guy.toner@petermac.org    Principal Investigator: Guy Toner          Austin Health Recruiting Heidelberg, Victoria, Australia, 3084 Contact: Jaren Caine       Jaren.Caine@austin.org.au    Contact: Andrew Weickhardt       Andrew.Weickhardt@ludwig.edu.au    Principal Investigator: Andrew Weickhardt          Sunshine Hospital Recruiting St Albans, Victoria, Australia, 3021 Contact: Jessica Tanner       Jessica.Tanner@wh.org.au    Contact: Shirley Wong       shirleys.wong@mh.org.au    Principal Investigator: Shirley Wong          Border Medical Oncology Recruiting Wodonga, Victoria, Australia, 3690 Contact: Lauren Callow       lcallow@bordermedonc.com.au    Contact: Craig Underhill       cunderhill@bordermedonc.com.au    Principal Investigator: Craig Underhill          Australia, Western Australia Fiona Stanley Hospital Recruiting Murdoch, Western Australia, Australia, 6847 Contact: Jaye Harding       jaye.harding@health.wa.gov.au    Contact: Simon Troon       simon.troon@health.wa.gov.au    Principal Investigator: Simon Troon          New Zealand Auckland Hospital Recruiting Grafton, Auckland, New Zealand, 1142 Contact: Andrew Conley       andrewcon@adhb.govt.nz    Contact: Fritha Hanning       FrithaH@adhb.govt.nz    Principal Investigator: Fritha Hanning          Palmerston North Hospital Recruiting Roslyn, Palmerston North, New Zealand, 4442 Contact: Sarah Holwell       Sarah.Holwell@midcentraldhb.govt.nz    Contact: Gary Forgeson       Garry.Forgeson@midcentraldhb.govt.nz    Principal Investigator: Gary Forgeson          Christchurch Hospital Recruiting Christchurch, New Zealand, 8011 Contact: Elizabeth Thompson       liz.thompson@cdhb.health.nz    Contact: Mark Jeffrey       Mark.jeffery@cdhb.health.nz    Principal Investigator: Mark Jeffrey          Dunedin Hospital Recruiting Dunedin, New Zealand, 9054 Contact: Rachel McLay-Barnes       ONCRESEARCH@southerndhb.govt.nz    Contact: David Perez       david.perez@southerndhb.govt.nz    Principal Investigator: David Perez Less <<
NCT02104986 Extra Cranial Non Seminomateou... More >>s Malignant Germ Cell Tumour Less << Phase 2 Recruiting May 2024 France ... More >> CHU Not yet recruiting Amiens, France, 80054 Principal Investigator: Catherine DEVOLDERE          CHU Recruiting Angers, France, 49033 Principal Investigator: Isabelle PELLIER          CHRU Not yet recruiting Besançon, France, 25030 Principal Investigator: Véronique LAITHIER          CHU Recruiting Bordeaux, France, 33076 Principal Investigator: Cécile VERITE          Chu Morvan Not yet recruiting Brest, France, 26609 Principal Investigator: Philippe LEMOINE          CHU Not yet recruiting Caen, France, 14033 Principal Investigator: Odile MINCKES          Chu Estaing Not yet recruiting Clermont-ferrand, France, 63003 Principal Investigator: Eric DORE          CHU Not yet recruiting Dijon, France, 21079 Principal Investigator: GERARD COUILLAULT          Centre Oscar Lambret Recruiting Lille, France, 59000 Principal Investigator: HELENE SUDOUR          CHU Not yet recruiting Limoges, France, 87042 Principal Investigator: CHRISTOPHE PIGUET          Hopital de La Timone Recruiting Marseille, France, 13385 Principal Investigator: ANGELIQUE ROME          CHU Not yet recruiting Montpellier, France, 34295 Principal Investigator: NICOLAS KALFA          CHU Recruiting Nancy, France, 54511 Principal Investigator: PASCAL CHASTAGNER          CHU Recruiting Nantes, France, 44093 Principal Investigator: ESTELLE THEBAUD          CHU Recruiting Nice, France, 06202 Principal Investigator: MARILYNE POIREE          Institut Curie Not yet recruiting Paris, France, 75005 Principal Investigator: DANIEL ORBACH          Hopital Trousseau Not yet recruiting Paris, France, 75012 Principal Investigator: SYLVIE FASOLA          CHU Not yet recruiting Poitiers, France, 86021 Principal Investigator: FREDERIC MILLOT          CHU Not yet recruiting Reims, France, 51092 Principal Investigator: MARTINE MUNZER          CHU Not yet recruiting Rennes, France, 35203 Principal Investigator: VIRGINIE GANDEMER          CHU Recruiting Rouen, France, 76031 Principal Investigator: CECILE DUMESNIL DE MARICOURT          Hopital Felix Guyon Not yet recruiting Saint Denis, France, 97405 Principal Investigator: MATHILDE JEHANNE          CHRU Recruiting Saint Etienne, France, 42055 Principal Investigator: CLAIRE BERGER          CHRU Not yet recruiting Strasbourg, France, 67098 Principal Investigator: PATRICK LUTZ          CHU Not yet recruiting Toulouse, France, 31059 Principal Investigator: MARIE PIERRE CASTEIX          CHRU Not yet recruiting Tours, France, 37044 Principal Investigator: ODILE LEJARS          Institut Gustave Roussy Not yet recruiting Villejuif, France, 94805 Principal Investigator: VERONIQUE MINARD Less <<
NCT02161692 Testicular Neoplasms ... More >> Germ Cell Tumors Less << Phase 2 Completed - Italy ... More >> Istituto Nazionale dei Tumori Milano, Italy, 20133 Less <<
NCT00722865 - Terminated(slow enrollment) - -
NCT01712490 - Active, not recruiting - -
NCT01322100 Brain Metastases ... More >> CNS Metastases Less << Phase 1 Terminated(Due to slow patient... More >> recruitment) Less << - Denmark ... More >> Rigshospitalet Copenhagen, Denmark, 2100 Herlev Hospital Herlev, Denmark, 2730 Less <<
NCT00722865 Hodgkin Lymphoma Phase 2 Terminated(slow enrollment) - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT02352259 Liver Metastases Phase 2 Unknown December 2016 Slovenia ... More >> Faculty of Electrical Engineering, University of Ljubljana, Slovenia Recruiting Ljubljana, Slovenia, 1000 Sub-Investigator: Damijan Miklavcic, PhD          Sub-Investigator: Tomaz Jarm, PhD          Sub-Investigator: Denis Pavliha, PhD          Sub-Investigator: Bor Kos, PhD          Sub-Investigator: Marija Marcan, Msc          Institute of Oncology Ljubljana Recruiting Ljubljana, Slovenia, 1000 Contact: Violeta Kaluza    +386 1 5879 122    vkaluza@onko-i.si    Principal Investigator: Ibrahim Edhemovic, MD, PhD          Sub-Investigator: Gregor Sersa, PhD          Sub-Investigator: Marko Snoj, MD, PhD          Sub-Investigator: Janja Ocvirk, MD, PhD          Sub-Investigator: Maja Music, MD, PhD          Sub-Investigator: Gorana Gasljevic, MD, PhD          Sub-Investigator: Maja Cemazar, PhD          Sub-Investigator: Tjasa Pecnik, BSc          Sub-Investigator: Masa Bosnjak, MPharm          University Medical Centre Ljubljana, Ljubljana, Slovenia Recruiting Ljubljana, Slovenia, 1000 Principal Investigator: Blaz Trotovsek, MD, PhD          Sub-Investigator: Mihajlo Djokic, MD          Sub-Investigator: Valentin Sojar, MD          Sub-Investigator: Vojka Gorjup, MD          Sub-Investigator: Miha Petric, MD          University Medical Centre Maribor, Maribor, Slovenia Recruiting Maribor, Slovenia, 2000 Principal Investigator: Stojan Potrc, MD, PhD          Sub-Investigator: Arpad Ivanecz, MD, PhD Less <<
NCT00000987 Sarcoma, Kaposi ... More >> HIV Infections Less << Phase 1 Completed - United States, California ... More >> UCLA CARE Center CRS Los Angeles, California, United States, 90095 Less <<
NCT01712490 Hodgkin Lymphoma Phase 3 Active, not recruiting March 1, 2020 -
NCT00992030 Hodgkin Lymphoma Phase 3 Active, not recruiting December 2019 United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Italy Ospedali Riuniti Umberto I Ancona, Italy, 60020 Ospedali Riuniti Bergamo, Italy, 24100 Policlinico S. Orsola Malpighi Bologna, Italy, 40138 Ospedale Roberto Binaghi Cagliari, Italy, 09126 Azienda Ospedaliera Vittorio Emanuele Ferrarotto Catania, Italy, 95124 Fondazione IRCCS Istituto Nazionale Tumori Milano, Italy, 20133 Azienda Ospedaliero Universitaria S. Luigi Gonzaga Orbassano, Italy, 10043 Gianpietro Semenzato Padova, Italy, 35128 Ospedali Riuniti Villa Sofia Cervello Palermo, Italy, 90146 Ospedale San Carlo Potenza, Italy, 85100 Less <<
NCT00918593 Ulcerated Cutaneous Metastases Phase 2 Withdrawn(No recruitment of pa... More >>tients) Less << February 2014 Denmark ... More >> Copenhagen University Hospital at Herlev Herlev, Copenhagen, Denmark, 2730 Less <<
NCT02166463 Ann Arbor Stage IIB Hodgkin Ly... More >>mphoma Ann Arbor Stage IIIB Hodgkin Lymphoma Ann Arbor Stage IV Hodgkin Lymphoma Ann Arbor Stage IVA Hodgkin Lymphoma Ann Arbor Stage IVB Hodgkin Lymphoma Childhood Hodgkin Lymphoma Classic Hodgkin Lymphoma Less << Phase 3 Recruiting - -
NCT02549742 Head Neck Cancer Phase 2 Recruiting September 2019 Denmark ... More >> Department of Otorhinolaryngology, Rigshospitalet, Copenhagen University Hospital Recruiting Copenhagen, Denmark, 2100 Contact: Christina C. Plaschke, MD    +45 29 25 92 45    caroline@dadlnet.dk    Contact: Irene Wessel, MD    +45 35 45 83 22    irene.wessel.01@regionh.dk Less <<
NCT00504504 Lymphoma Phase 2 Completed - United States, Texas ... More >> UT MD . Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03199300 - Recruiting January 2021 Netherlands ... More >> University Medical Center Groningen Recruiting Groningen, Netherlands, 9713 GZ Contact: J.A. Gietema, MD, PhD    +31 50 3612821    j.a.gietema@umcg.nl    Contact: L.C. Steggink, MD    +31 50 3612821    l.c.steggink@umcg.nl    Principal Investigator: J.A. Gietema, MD, PhD Less <<
NCT00744653 Breast Cancer Phase 2 Terminated(Primary endpoint me... More >>asure not suitable for evaluation) Less << - Denmark ... More >> Herlev Hospital, Herlev Ringvej 75 Herlev, Denmark, DK-2730 Less <<
NCT01941901 Cutaneous Metastases Phase 2 Unknown April 2018 Denmark ... More >> Department of Oncology, Copenhagen University Hospital, Herlev Recruiting Herlev, Denmark, 2730 Contact: Julie Gehl    004538683868    julie.gehl@regionh.dk    Principal Investigator: Julie Gehl Less <<
NCT00744653 - Terminated(Primary endpoint me... More >>asure not suitable for evaluation) Less << - -
NCT00504504 - Completed - -
NCT00003811 Childhood Germ Cell Tumor ... More >> Drug/Agent Toxicity by Tissue/Organ Extragonadal Germ Cell Tumor Ovarian Cancer Less << Phase 2 Completed - -
NCT01067690 Kaposi's Sarcoma Phase 2 Completed - Italy ... More >> Dermatologic Unit, Ospedale Maggiore Policlinico, Milan, Italy Milan, Italy, 20100 Less <<
NCT00004010 Lymphoma Phase 2 Completed - -
NCT01264952 Liver Metastases Phase 1 Phase 2 Completed - Slovenia ... More >> Institute of Oncology Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT02291133 Liver Cancer Phase 1 Phase 2 Unknown July 2017 Slovenia ... More >> University Medical Centre Ljubljana, Ljubljana, Slovenia Recruiting Ljubljana, Slovenia, 1000 Less <<
NCT00000954 Sarcoma, Kaposi ... More >> HIV Infections Less << Phase 1 Completed - United States, California ... More >> USC CRS Los Angeles, California, United States, 90033 UCLA CARE Center CRS Los Angeles, California, United States, 90095 Ucsf Aids Crs San Francisco, California, United States United States, Colorado University of Colorado Hospital CRS Aurora, Colorado, United States, 80262 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States United States, Indiana Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States, 46202 United States, Maryland Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States United States, Massachusetts Bmc Actg Crs Boston, Massachusetts, United States, 02118 United States, Missouri Washington U CRS St. Louis, Missouri, United States United States, New York SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States, 14215 Memorial Sloan-Kettering Cancer Ctr. New York, New York, United States, 10021 United States, North Carolina Unc Aids Crs Chapel Hill, North Carolina, United States, 27599 United States, Ohio The Ohio State Univ. AIDS CRS Columbus, Ohio, United States, 43210 Less <<
NCT01264952 - Completed - -
NCT00079105 Lymphoma Phase 2 Completed - -
NCT00276718 Brain and Central Nervous Syst... More >>em Tumors Childhood Germ Cell Tumor Extragonadal Germ Cell Tumor Ovarian Cancer Less << Not Applicable Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT03040180 Locally Advanced Rectal Cancer... More >> Electrochemotherapy Neoadjuvant Therapy Down Staging Less << Phase 2 Recruiting December 2018 Denmark ... More >> Department of Oncology Recruiting Herlev, Capitol Region, Denmark, 2730 Contact: Julie Gehl, MD, DMSc    +45 38683868    karen.julie.gehl@regionh.dk    Department of Surgery Recruiting Roskilde, Denmark, 4000 Contact: Ismail Gögenur, MD, DMSc    +45 26336426    igo@regionsjaelland.dk    Contact: Rasmus P Vogelsang, MD    +45 27351103 Less <<
NCT00066482 Childhood Germ Cell Tumor ... More >> Extragonadal Germ Cell Tumor Less << Not Applicable Completed - -
NCT02429700 Ovarian Sex Cord Stromal Tumor... More >> Ovarian Neoplasms Ovarian Cancer Less << Phase 3 Recruiting May 2024 China, Shandong ... More >> Qilu Hospital of Shandong University Recruiting Jinan, Shandong, China Contact: Beihua Kong, MD. PhD. Less <<
NCT00000681 Sarcoma, Kaposi ... More >> HIV Infections Less << Phase 1 Completed - United States, California ... More >> USC CRS Los Angeles, California, United States, 900331079 UCLA CARE Center CRS Los Angeles, California, United States, 90095 United States, Massachusetts Beth Israel Deaconess Med. Ctr., ACTG CRS Boston, Massachusetts, United States, 02215 United States, New York SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States, 14215 United States, Pennsylvania Pitt CRS Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02429687 Ovarian Germ Cell Cancer ... More >> Ovarian Neoplasms Ovarian Cancer Less << Phase 3 Recruiting May 2024 China, Shandong ... More >> Qilu Hospital of Shandong University Recruiting Jinan, Shandong, China, 250012 Contact: Beihua Kong, MD. PhD.    +8618560081888    kongbeihua@sdu.edu.cn Less <<
NCT00983944 Lymphoma Phase 2 Withdrawn(Inadequate Accrual) - -
NCT00002093 Sarcoma, Kaposi ... More >> HIV Infections Less << Phase 3 Completed - United States, Arizona ... More >> Univ of Arizona / Arizona Cancer Ctr Tucson, Arizona, United States, 85724 United States, California Kenneth Norris Jr Cancer Hosp Los Angeles, California, United States, 90033 Desert Hosp Comprehensive Cancer Ctr Palm Springs, California, United States, 92262 Saint Francis Mem Hosp San Francisco, California, United States, 94109 Davies Med Ctr San Francisco, California, United States, 94114 United States, Colorado Denver Gen Hosp Denver, Colorado, United States, 802044507 United States, District of Columbia George Washington Univ Med Ctr Washington, District of Columbia, United States, 20037 United States, Florida Univ of Miami Dept of Medicine Miami, Florida, United States, 33136 United States, Illinois Northwestern Univ Med School Chicago, Illinois, United States, 60611 United States, Massachusetts New England Deaconess Hosp Boston, Massachusetts, United States, 02215 United States, New York New York Univ Med Ctr New York, New York, United States, 10016 United States, Oregon Kaiser Permanente Med Ctr Portland, Oregon, United States, 97227 United States, Texas Dr Edward Stool Houston, Texas, United States, 77004 Less <<
NCT00165438 - Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT03067181 Adult Germ Cell Tumor ... More >> Childhood Extracranial Germ Cell Tumor Childhood Germ Cell Tumor Extragonadal Embryonal Carcinoma Grade 2 Immature Ovarian Teratoma Grade 3 Immature Ovarian Teratoma Malignant Germ Cell Tumor Stage I Ovarian Choriocarcinoma Stage I Ovarian Embryonal Carcinoma Stage I Ovarian Teratoma Stage I Ovarian Yolk Sac Tumor Stage I Testicular Choriocarcinoma AJCC v6 and v7 Stage I Testicular Embryonal Carcinoma AJCC v6 and v7 Stage I Testicular Yolk Sac Tumor AJCC v6 and v7 Stage II Ovarian Choriocarcinoma Stage II Ovarian Embryonal Carcinoma Stage II Ovarian Yolk Sac Tumor Stage II Testicular Choriocarcinoma AJCC v6 and v7 Stage II Testicular Embryonal Carcinoma AJCC v6 and v7 Stage II Testicular Yolk Sac Tumor AJCC v6 and v7 Stage III Ovarian Choriocarcinoma Stage III Ovarian Embryonal Carcinoma Stage III Ovarian Yolk Sac Tumor Stage III Testicular Choriocarcinoma AJCC v6 and v7 Stage III Testicular Embryonal Carcinoma AJCC v6 and v7 Stage III Testicular Yolk Sac Tumor AJCC v6 and v7 Stage IV Ovarian Choriocarcinoma Stage IV Ovarian Embryonal Carcinoma Stage IV Ovarian Yolk Sac Tumor Testicular Mixed Choriocarcinoma and Embryonal Carcinoma Testicular Mixed Choriocarcinoma and Teratoma Testicular Mixed Choriocarcinoma and Yolk Sac Tumor Less << Phase 3 Recruiting June 30, 2027 -
NCT00002318 Sarcoma, Kaposi ... More >> HIV Infections Less << Phase 3 Unknown - United States, California ... More >> East Bay AIDS Ctr Berkeley, California, United States, 94705 Pacific Oaks Med Group Beverly Hills, California, United States, 90211 Hematology - Oncology Med Group of San Fernando Valley Encino, California, United States, 91436 Dr Becky Miller Los Angeles, California, United States, 90048 Apogee Med Group San Diego, California, United States, 92103 UCSF - San Francisco Gen Hosp San Francisco, California, United States, 94110 Kaiser Permanente Med Ctr San Francisco, California, United States, 94115 UCSF San Francisco, California, United States, 94117 San Francisco Veterans Administration Med Ctr San Francisco, California, United States, 94121 UCSF San Francisco, California, United States, 941430324 Pacific Oaks Med Group Sherman Oaks, California, United States, 91403 United States, District of Columbia Dr Mahmoud Mustafa Washington, District of Columbia, United States, 20037 United States, Florida Univ of Miami School of Medicine Miami, Florida, United States, 33136 H Lee Moffit Cancer Ctr and Research Institute Tampa, Florida, United States, 33612 United States, Georgia American Med Research Institute Atlanta, Georgia, United States, 30329 Infectious Disease Rsch Consortium of GA / SE Clin Resources Atlanta, Georgia, United States, 30345 United States, Illinois Northwestern Med Faculty Foundation Chicago, Illinois, United States, 60611 Rush Presbyterian Med College Chicago, Illinois, United States, 60612 Illinois Masonic Med Ctr / The Cancer Ctr Chicago, Illinois, United States, 60657 United States, Michigan Henry Ford Hosp Detroit, Michigan, United States, 48202 United States, Missouri Washington Univ St Louis, Missouri, United States, 63108 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Saint Vincent's Hosp and Med Ctr New York, New York, United States, 10011 New York Univ Med Ctr New York, New York, United States, 10016 Saint Luke's - Roosevelt Hosp Ctr New York, New York, United States, 10023 United States, Pennsylvania Graduate Hosp / Tuttleman Cancer Ctr Philadelphia, Pennsylvania, United States, 19146 United States, Texas Comprehensive Care Ctr Dallas, Texas, United States, 75235 Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00324298 Drug/Agent Toxicity by Tissue/... More >>Organ Testicular Germ Cell Tumor Less << Phase 3 Completed - United Kingdom ... More >> Basildon University Hospital Basildon, England, United Kingdom, SS16 5NL Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Essex County Hospital Colchester, England, United Kingdom, C03 3NB Ipswich Hospital Ipswich, England, United Kingdom, IP4 5PD Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE University College of London Hospitals London, England, United Kingdom, WIT 3AA Norfolk and Norwich University Hospital Norwich, England, United Kingdom, NR4 7UY Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Southend University Hospital NHS Foundation Trust Westcliff-On-Sea, England, United Kingdom, SS0 0RY Less <<
NCT00797472 Hodgkin's Disease Phase 2 Unknown April 2014 United States, New Jersey ... More >> Raritan Bay Medical Center Not yet recruiting Englishtown, New Jersey, United States, 07726 Contact: Prem A Nandiwada, M.D.    908-941-5480    rgreywal@americanscitech.com    Contact: Ratna Grewal, M.D.    908-941-5480    rgreywal@americanscitech.com Less <<
NCT00002105 Sarcoma, Kaposi ... More >> HIV Infections Less << Phase 3 Completed - United States, Massachusetts ... More >> Beth Israel Hosp Boston, Massachusetts, United States, 02215 United States, New York Mount Sinai Med Ctr New York, New York, United States, 10029 United States, Texas Twelve Oaks Hosp Houston, Texas, United States, 77074 United States, Washington Virginia Mason Research Center / Clinical Trial Unit Seattle, Washington, United States, 98101 Less <<
NCT02341989 Testicular Neoplasms ... More >> Seminoma Less << Phase 3 Recruiting December 2020 Norway ... More >> Institutt for kreftforskning og molekylær medisin, St Olavs Hospital Recruiting Trondheim, Norway Contact: Torgrim Tandstad, md phd       torgrim.tandstad@ntnu.no Less <<
NCT00993512 Head and Neck Neoplasms ... More >> Skin Neoplasms Less << Phase 1 Completed - United Kingdom ... More >> University College London Hospital London, United Kingdom, NW1 2PG Less <<
NCT00132613 Malignant Pericardial Effusion Phase 3 Completed - Japan ... More >> Aichi Cancer Center Hospital Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi, Japan, 464-8681 Aichi Cancer Center,Aichi Hospital Okazaki,Kake-machi,Kuriyado,18, Aichi, Japan, 444-0011 National Cancer Center Hospital East Kashiwa,Kashiwanoha,6-5-1, Chiba, Japan, 277-8577 National Hospital Organization Shikoku Cancer Center Matsuyama,Horinouchi,13, Ehime, Japan, 790-0007 Kyushu University Hospital Fukuoka,Higashi-ku,Maidashi,3-1-1, Fukuoka, Japan, 812-8582 Gifu Municipal Hospital Gifu,Kashima-cho,7-1, Gifu, Japan, 500-8323 Gunma Prefectural Cancer Center Ota,Takabayashi-nishi-cho,617-1, Gunma, Japan, 373-8550 National Nishigunma Hospital Shibukawa,Kanai,2854, Gunma, Japan, 377-8511 National Hospital Organization, Dohoku National Hospital Asahikawa,Hanasaki,7-4048, Hokkaido, Japan, 070-8644 National Hospital Organization Hokkaido Cancer Center Sapporo,Shiroishi-ku,Kikusui,4-2-3-54, Hokkaido, Japan, 003-0804 Kobe City General Hospital Kobe,Chuo-ku,Minatojimanakamachi,4-6, Hyogo, Japan, 650-0046 Hyogo College of Medicine Nishinomiya,Mukogawa-cho,1-1, Hyogo, Japan, 663-8501 Ibaraki Kenritsu Chuo Hospital & Cancer Center Nishi-ibarakigun,Tomobemachi,Koibuchi,6528, Ibaraki, Japan, 309-1793 Kanagawa Cancer Center Yokohama,Asahi-ku,Nakao,1-1-2, Kanagawa, Japan, 241-0815 Yokohama Mucipical Citizen's Hospital Yokohama,Hodogaya-ku,Okazawa-cho,56, Kanagawa, Japan, 240-8555 Kumamoto Regional Medical Center Hospital Kumamoto,Honjo,5-16-10, Kumamoto, Japan, 860-0811 Tohoku University Hospital Sendai,Aoba-ku,Seiryo-machi,1-1, Miyagi, Japan, 980-8574 Niigata Cancer Center Hospital Niigata,Kawagishi-cho,2-15-3, Niigata, Japan, 951-8566 Osaka Prefectural Medical Center for Respiratory and Allergic Disease Habikino,Habikino,3-7-1, Osaka, Japan, 583-8588 Rinku General Medical Center Izumisano,rinku-ohrai-kita,2-23, Osaka, Japan, 598-0048 Graduate School of Medicine, Osaka City University Osaka,Abeno-ku,Asahi-machi,1-5-7, Osaka, Japan, 545-0051 Osaka Medical Center for Cancer and Cardiovascular Diseases Osaka,Higashinari-ku,Nakamichi,1-3-3, Osaka, Japan, 537-8511 Kinki University School of Medicine Osaka-Sayama,Ohno-higashi,377-2, Osaka, Japan, 589-8511 National Hospital Organization Kinki-Chuo Chest Medical Center Sakai,Nagasone,1180, Osaka, Japan, 591-8555 National Hospital Organization Toneyama National Hospital Toyonaka,Toneyama,5-1-1, Osaka, Japan, 560-8552 Saitama Cancer Center Kita-adachi,Ina,Komuro,818, Saitama, Japan, 362-0806 Tochigi Cancer Center Utsunomiya,Yohnan,4-9-13, Tochigi, Japan, 320-0834 National Cancer Center Hospital Chuo-ku,Tsukiji, 5-1-1, Tokyo, Japan, 104-0045 Cancer Institute Hospital Koto-ku,Ariake,3-10-6, Tokyo, Japan, 135-8550 International Medical Center of Japan Shinjuku-ku,Toyama,1-21-1, Tokyo, Japan, 162-8655 Yamagata Prefectural Central Hospital Yamagata,Aoyagi,1800, Yamagata, Japan, 990-2292 Less <<
NCT01873326 Germ Cell Tumors Phase 2 Active, not recruiting June 2019 United States, California ... More >> University of Southern California Los Angeles, California, United States, 90033 Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Illinois University of Chicago Chicago, Illinois, United States United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New Jersey Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27514 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01404936 - Completed - -
NCT00006035 Melanoma (Skin) Phase 1 Unknown - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00001059 Sarcoma, Kaposi ... More >> HIV Infections Less << Phase 2 Completed - United States, Alabama ... More >> Alabama Therapeutics CRS Birmingham, Alabama, United States, 35294 United States, California USC CRS Los Angeles, California, United States, 90033 UCLA CARE Center CRS Los Angeles, California, United States, 90095 Ucsf Aids Crs San Francisco, California, United States United States, Colorado University of Colorado Hospital CRS Aurora, Colorado, United States, 80262 United States, Florida Univ. of Miami AIDS CRS Miami, Florida, United States, 33136 United States, Hawaii Queens Med. Ctr. Honolulu, Hawaii, United States, 96813 Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu, Hawaii, United States, 96816 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States, 60612 United States, Indiana Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States, 46202 United States, Massachusetts Bmc Actg Crs Boston, Massachusetts, United States, 02118 Beth Israel Deaconess - East Campus A0102 CRS Boston, Massachusetts, United States, 02215 Massachusetts General Hospital ACTG CRS Boston, Massachusetts, United States United States, Missouri Washington U CRS St. Louis, Missouri, United States, 63110 United States, New York SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States, 14215 Memorial Sloan-Kettering Cancer Ctr. New York, New York, United States, 10021 Less <<
NCT00027521 Pancreatic Cancer Phase 1 Withdrawn(Program terminated) - -
NCT00002872 Metastatic Cancer Phase 3 Completed - -
NCT01606566 Recurrent Head and Neck Cancer... More >> Carcinoma, Squamous Cell of Head and Neck Less << Phase 2 Terminated(Business reasons) - France ... More >> CHU de Nantes Hôtel Dieu Nantes, Nantes Cedex 1, France, 44093 Centre Alexis Vautrin (CAV)-Nancy Université Nancy, France Germany Universitätsklinikum Schleswig-Holstein Lübeck, Schleswig-Holstein, Germany, 23538 Charité Comprehensive Cancer Center Berlin, Germany, 10117 Universitätsklinikum Essen Essen, Germany, 45147 Ludwig Maximilian University Munich München, Germany Lithuania Institute of Oncology, Vilnius University Vilnius, Lithuania, 08660 Netherlands The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands Poland Szpital Specjalistyczny w Brzozowie Brzozów, Poland United Kingdom University College London Hospital London, United Kingdom Less <<
NCT01404936 Lymphoma Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00006916 - Terminated(Low accrual) - -
NCT02883023 Capillary Malformations ... More >> Vascular Malformations Less << Phase 2 Recruiting March 2018 Netherlands ... More >> Academic Medical Center (AMC) Recruiting Amsterdam, Noord-Holland, Netherlands, 1105AZ Contact: Sophie E Horbach, MD    0031205666679    s.e.horbach@amc.uva.nl    Contact: Albert Wolkerstorfer, MD PhD       a.wolkerstorfer@amc.uva.nl    Sub-Investigator: Sophie E Horbach, MD          Principal Investigator: Chantal M van der Horst, MD PhD          Sub-Investigator: Albert Wolkerstorfer, MD PhD          Sub-Investigator: Martijn de Bruin, MSc PhD Less <<
NCT03225781 Pancreatic Cancer Not Applicable Recruiting June 15, 2020 Italy ... More >> University of Verona Hospital Recruiting Verona, Italy, 37134 Contact: Salvatore Paiella, MD    +390458126009    salvatore.paiella@aovr.veneto.it    Principal Investigator: Salvatore Paiella, MD          Sub-Investigator: Luca Landoni, MD          Sub-Investigator: Alessandro Esposito, MD          Sub-Investigator: Luca Casetti, MD          Principal Investigator: Claudio Bassi, MD, FRCS, FACS, FEBS Less <<
NCT01347294 Venous Malformation Phase 4 Recruiting December 2018 Norway ... More >> Oslo Universitetssykehus Rikshospitalet Recruiting Oslo, Norway, 0227 Contact: Rune Andersen, MD    +4723073992    randerse@ous-hf.no Less <<
NCT03649113 Hemangioma Liver Phase 1 Not yet recruiting September 15, 2020 -
NCT00006916 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Terminated(Low accrual) - United States, Arizona ... More >> Foundation for Cancer Research and Education Phoenix, Arizona, United States, 85013 United States, Kentucky Markey Cancer Center at University of Kentucky Chandler Medical Center Lexington, Kentucky, United States, 40536-0293 United States, Nebraska Methodist Hospital Cancer Center at Nebraska Methodist Hospital - Omaha Omaha, Nebraska, United States, 68114-4199 United States, New Jersey South Jersey Regional Cancer Center Millville, New Jersey, United States, 08332 Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Mount Holly, New Jersey, United States, 08060 United States, Ohio Cancer Treatment Center Wooster, Ohio, United States, 44691 United States, Oklahoma St. John Health System Tulsa, Oklahoma, United States, 74104 United States, Utah Cottonwood Hospital Medical Center Murray, Utah, United States, 84107 Utah Valley Regional Medical Center - Provo Provo, Utah, United States, 84604 Dixie Regional Medical Center Saint George, Utah, United States, 84770 LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Wisconsin CCOP - Marshfield Clinic Research Foundation Marshfield, Wisconsin, United States, 54449 Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226 Less <<
NCT03628417 Cutaneous Melanoma Not Applicable Enrolling by invitation March 31, 2019 -
NCT01042522 Ovarian Granulosa Cell Tumor ... More >> Ovarian Gynandroblastoma Ovarian Sertoli-Leydig Cell Tumor Ovarian Sex Cord Tumor With Annular Tubules Ovarian Sex Cord-Stromal Tumor Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types Ovarian Steroid Cell Tumor Less << Phase 2 Recruiting - -
NCT00198328 Head Neck Cancer Phase 3 Withdrawn(Enrollment was stopp... More >>ed based on the Data Monitoring Committee's recommendation.) Less << - United States, California ... More >> Inovio Biomedical Corporation San Diego, California, United States, 92121 Less <<
NCT03596918 AIDS-Related Kaposi Sarcoma ... More >> Human Immunodeficiency Virus 1 Positive Less << Phase 1 Recruiting March 31, 2020 Tanzania ... More >> Bugando Medical Centre Recruiting Mwanza, Tanzania Contact: Nestory Masalu    255-783-0-00004    nmasalu2000@yahoo.com    Principal Investigator: Nestory Masalu, MD MMed Less <<
NCT03477448 Warts Phase 4 Not yet recruiting April 1, 2020 -
NCT00003110 Lymphoma Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00198263 Head and Neck Cancer Phase 4 Completed - United States, California ... More >> Inovio Biomedical Corporation San Diego, California, United States, 92121 Less <<
NCT00198276 Cancer Phase 4 Completed - United States, California ... More >> Inovio Biomedical Corporation San Diego, California, United States, 92121 Less <<
NCT00198315 Head and Neck Cancer Phase 3 Withdrawn(Enrollment was stopp... More >>ed based on the Data Monitoring Committee's recommendation.) Less << - United States, California ... More >> Inovio Biomedical Corporation San Diego, California, United States, 92121 Less <<
NCT01872923 Cutaneous or Sub-cutaneous Mal... More >>ignancies Less << Phase 1 Completed - United Kingdom ... More >> University College London Hospital London, United Kingdom Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

0.66mL

0.13mL

0.07mL

3.31mL

0.66mL

0.33mL

6.61mL

1.32mL

0.66mL

 

Historical Records

Categories